Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 12, Number 6—June 2006


VIM-1 Metallo-β-lactamase in Acinetobacter baumannii

Athanassios Tsakris*Comments to Author , Alexandros Ikonomidis†, Spyros Pournaras†, Leonidas S. Tzouvelekis*, Danai Sofianou‡, Nicholas J. Legakis*, and Antonios N. Maniatis†
Author affiliations: *University of Athens, Athens, Greece; †University of Thessalia, Larissa, Greece; ‡Hippokration University Hospital, Thessaloniki, Greece

Main Article


Characteristics of blaVIM-1-bearing Acinetobacter baumannii isolates*†

Isolate no. Region of isolation Material PFGE type Etest IMP MIC (μg/mL) Etest MBL (IMP+EDTA) Etest MER MIC (μg/mL) blaOXA-51-like status blaOXA-58 status
1 Thessaloniki Blood Ia 4 <1 2 +
2 Thessalia Bronchial fluid II 32 2 4 + +
3 Thessalia CSF III 4 <1 2
4 Thessalia Blood IV >32 1 32 +
5 Thessaloniki Urine Ib 8 <1 4 + +

*The 5 isolates exhibited resistance to all alternative antimicrobial drugs except colistin.
†PFGE, pulsed-field gel electrophoresis; IMP, imipenem; MBL, metallo-β-lactamase; MER, meropenem; CSF, cerebrospinal fluid.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO